2566 — Hangzhou Jiuyuan Genetic Biopharmaceutical Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$1.92bn
- HK$1.48bn
- CNY1.37bn
- 72
- 50
- 30
- 51
Annual balance sheet for Hangzhou Jiuyuan Genetic Biopharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 128 | 116 | 126 | 611 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 409 | 460 | 526 | 639 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 748 | 759 | 840 | 1,410 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 405 | 389 | 377 | 355 |
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | 1,183 | 1,214 | 1,308 | 1,923 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 401 | 356 | 348 | 342 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 465 | 447 | 410 | 405 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 718 | 766 | 898 | 1,518 |
| Total Liabilities & Shareholders' Equity | 1,183 | 1,214 | 1,308 | 1,923 |
| Total Common Shares Outstanding |